• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Mandy Moore to serve as brand ambassador for Lumenis’ OptiLight


Moore suffered from dry eye disease and Lumenis noted that treatment with OptiLight improved her condition. Now she’s partnering with the company to share her story and empower others.

Lumenis is partnering with singer-songwriter and actress Mandy Moore as a brand ambassador for OptiLight, a bright solution for dry eyes.

According to the company’s news release, Moore suffered from dry eye disease and treatment with OptiLight improved her condition. Now she’s partnering with Lumenis to share her story and empower others. She will star in OptiLight’s new campaign, showing millions of dry eye sufferers that they don’t have to “just live with it."

Before she was diagnosed, Moore didn’t realize that her dry, itchy, burning eyes were actually signs of dry eye disease, which affects an estimated 49 million Americans, yet only half are diagnosed.1,2

Mandy Moore

Mandy Moore

To help dry eye sufferers like Moore, Lumenis recently launched OptiLight. This revolutionary, patented treatment is the first and only light-based therapy for dry eye disease. As part of a treatment regimen, OptiLight helps improve dry eye disease with a series of quick, gentle, in-office treatments.

“I’m excited to partner with Lumenis and share how OptiLight has made a real impact on my life,” Moore said in a statement. “For years, I suffered from dry eye disease, but I didn’t know I had it! My eyes felt gritty and tired, and they looked red. I couldn’t wear my contact lenses for long. Eye drops didn’t do much. It was a constant frustration on the set and at home with my family.”

Moore added that when she learned that she had dry eye disease, she realized she didn’t have to just live with it.

“I could get a safe, effective treatment with OptiLight,” she said. “Now, I can focus more time on what’s important to me, rather than battling the constant nuisance and discomfort of dry eye disease, and I want to inspire other people to say, ‘I won’t just live with it.’” 

The “Not Gonna Live With It Generation” campaign featuring Moore debuted Feb. 8 with a commercial as well as a digital and print media campaign to encourage people to learn more about dry eye disease and find effective therapy with OptiLight. 

Lumenis CEO Tzipi Ozer-Armon said the company was thrilled to partner with Mandy Moore for the campaign.

“Our ability to improve the quality of life for those who suffer from dry eye disease is why we do what we do, so it’s wonderful to see her enthusiasm for OptiLight and the results of her treatment,” Ozer-Armon said. “We hope it will inspire others to get better care for dry eye disease.”


1. Dana R et al. Patient-Reported Burden of Dry Eye Disease in the United States: Results of an Online Cross-Sectional Survey. Am J Ophthalmol. 2020 Aug; 216:7-17.

2. U.S. Census data.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.